Effect of Obesity, Dyslipidemia, and Diabetes on Trastuzumab-related Cardiotoxicity in Breast Cancer
Abstract
Share and Cite
Kosalka, P.; Johnson, C.; Turek, M.; Sulpher, J.; Law, A.; Botros, J.; Dent, S.; Aseyev, O. Effect of Obesity, Dyslipidemia, and Diabetes on Trastuzumab-related Cardiotoxicity in Breast Cancer. Curr. Oncol. 2019, 26, 314-321. https://doi.org/10.3747/co.26.4823
Kosalka P, Johnson C, Turek M, Sulpher J, Law A, Botros J, Dent S, Aseyev O. Effect of Obesity, Dyslipidemia, and Diabetes on Trastuzumab-related Cardiotoxicity in Breast Cancer. Current Oncology. 2019; 26(3):314-321. https://doi.org/10.3747/co.26.4823
Chicago/Turabian StyleKosalka, P., C. Johnson, M. Turek, J. Sulpher, A. Law, J. Botros, S. Dent, and O. Aseyev. 2019. "Effect of Obesity, Dyslipidemia, and Diabetes on Trastuzumab-related Cardiotoxicity in Breast Cancer" Current Oncology 26, no. 3: 314-321. https://doi.org/10.3747/co.26.4823